US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.50

-0.6200-2.47%

Post-market: 25.521.02+4.16%19:30 EDT

Volume:57.51K

Turnover:1.41M

Market Cap:56.84M

PE:- -

High:25.32

Open:25.24

Low:24.14

Close:25.12

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:1.27

T/O Rate:2.48%

Dividend:1.70

Dividend Rate:6.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

NRx Pharma to Present at Moody Capital Solutions Disruptive Growth & Life Sciences Conference

FBR raises A$4m to accelerate DST-powered robotics rollout

Mizuho survey shows no consensus into Alkermes ADHD data

Right Resources shareholders back director placements and capital raising

Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34

Compass Pathways Grants Inducement Equity Awards Covering 414,100 Shares to New Hires

CARDIO-TTRansform Update: What Eplontersen’s Phase 3 Completion Means for AstraZeneca Investors

WasteCo launches capital raising to fund Ashburton contract and turnaround plan

Talisman Mining Raises A$4 Million to Fast-Track Gold Exploration and Growth

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Compass Pathways to Join Cantor Global Healthcare Conference Fireside Chat

Dipietro Group Completes IPO Greenshoe, Raises €2.1 Million

Alvo Minerals shareholders back prior capital raisings at general meeting

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why

Unusually active option classes on open August 26th

COMPASS Pathways (CMPS) Nears FDA Filing for COMP360 Following a Valuation Question

Simply Wall St.

Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug

FireFly announces successful A$190m capital raising to fund development and resource growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PSIL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.5,"timestamp":1789502400000,"preClose":25.12,"halted":0,"volume":57505,"hourTrading":{"tag":"盘后","latestPrice":25.52,"preClose":24.5,"latestTime":"19:30 EDT","volume":168,"amount":4296.44,"timestamp":1789515005327,"change":1.02,"changeRate":0.041633,"amplitude":0.041633},"delay":0,"changeRate":-0.024681528662420422,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Closed","change":-0.62,"latestTime":"09-15 16:00:00 EDT","open":25.24,"high":25.3215,"low":24.14,"amount":1405286.14317,"amplitude":0.047034,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":25.12,"sharesOutstanding":1184976,"nav":25.051,"aum":58118072.21,"dividendRate":0.069514,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.52,"preClose":24.5,"latestTime":"19:30 EDT","volume":168,"amount":4296.44,"timestamp":1789515005327,"change":1.02,"changeRate":0.041633,"amplitude":0.041633},"volumeRatio":1.273508,"impliedVol":0.4953,"impliedVolPercentile":0.8446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.273508,"shares":2319976,"dividePrice":1.7031,"high":25.3215,"amplitude":0.047034,"preClose":25.12,"low":24.14,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.5,"eps":0,"divideRate":0.069514,"volume":57505,"delay":0,"ttmEps":0,"open":25.24,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.96,"twentyDayClose":25.83,"sixtyDayClose":20.0904},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665322488","title":"NRx Pharma to Present at Moody Capital Solutions Disruptive Growth & Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322488","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322488?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:06","pubTimestamp":1788865578,"startTime":"0","endTime":"0","summary":"NRx Pharma to present at Moody Capital Solutions Disruptive Growth & Life Sciences ConferenceNRx Pharmaceuticals management will present at investor conferences in New York on Sept. 9, Sept. 11, Sept.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1TRKCH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","CFSU","SG9999014005.SGD","IE00BN0W2V16.EUR","PSIL","NRXP","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","LU0314104364.USD","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","SG9999014021.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","NDAQ","IE00B3QW5Z07.USD","BK4007","IE00BGHQF748.EUR","BK4588","BCDF","BK4112","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665138360","title":"FBR raises A$4m to accelerate DST-powered robotics rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2665138360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665138360?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:51","pubTimestamp":1788738718,"startTime":"0","endTime":"0","summary":"The latest announcement is out from FBR Limited ( ($AU:FBR) ). FBR Limited has launched a A$4 million capital raising comprising a A$1.5 million sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fbr-raises-a4m-to-accelerate-dst-powered-robotics-rollout?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fbr-raises-a4m-to-accelerate-dst-powered-robotics-rollout?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DYNI","KOMP","PBOT","DARP","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665735956","title":"Mizuho survey shows no consensus into Alkermes ADHD data","url":"https://stock-news.laohu8.com/highlight/detail?id=2665735956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665735956?lang=en_us&edition=fundamental","pubTime":"2026-09-05 03:35","pubTimestamp":1788550508,"startTime":"0","endTime":"0","summary":"Mizuho conducted a survey of 13 investors ahead of Alkermes (ALKS)’ Phase 1b trial of ALKS-7290 in adult attention-deficit/hyperactivity disorder, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-survey-shows-no-consensus-into-alkermes-adhd-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-survey-shows-no-consensus-into-alkermes-adhd-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","ADHD","MEDX","IBRN","ALKS","PSCH","FBT","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386764","title":"Right Resources shareholders back director placements and capital raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386764","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386764?lang=en_us&edition=fundamental","pubTime":"2026-09-04 12:17","pubTimestamp":1788495451,"startTime":"0","endTime":"0","summary":"Right Resources Limited ( ($AU:RRE) ) has shared an announcement. Right Resources Limited has reported that all resolutions put to shareholders at ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/right-resources-shareholders-back-director-placements-and-capital-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/right-resources-shareholders-back-director-placements-and-capital-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802637","title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802637","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802637?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:33","pubTimestamp":1788474793,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin disposes of 2,034 common shares worth $97,651.34Alkermes EVP and chief legal officer David Joseph Gaffin sold 2,034 ordinary shares on Sep. 3, 2026 at USD 48.01.D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL5DSLJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4139","IBRN","ALKS","PSIL","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664014408","title":"Compass Pathways Grants Inducement Equity Awards Covering 414,100 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2664014408","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664014408?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:30","pubTimestamp":1788467422,"startTime":"0","endTime":"0","summary":"Compass Pathways grants inducement equity awards covering 414,100 shares to new hiresCompass Pathways granted inducement equity awards on Sept. 1, 2026 to 31 newly hired non-executive employees.Option","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1B01xs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338805","title":"CARDIO-TTRansform Update: What Eplontersen’s Phase 3 Completion Means for AstraZeneca Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338805","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664338805?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453041,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The CARDIO-TTRansform study is a Phase 3 trial that tests eplontersen in p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardio-ttransform-update-what-eplontersens-phase-3-completion-means-for-astrazeneca-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardio-ttransform-update-what-eplontersens-phase-3-completion-means-for-astrazeneca-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BBC","ISBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841116","title":"WasteCo launches capital raising to fund Ashburton contract and turnaround plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841116?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:47","pubTimestamp":1788382036,"startTime":"0","endTime":"0","summary":"WasteCo Group Limited ( ($NZ:WCO) ) has shared an update. WasteCo Group Limited has launched a capital raising comprising a placement and share pur...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wasteco-launches-capital-raising-to-fund-ashburton-contract-and-turnaround-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wasteco-launches-capital-raising-to-fund-ashburton-contract-and-turnaround-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664862521","title":"Talisman Mining Raises A$4 Million to Fast-Track Gold Exploration and Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2664862521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664862521?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:44","pubTimestamp":1788306290,"startTime":"0","endTime":"0","summary":"Talisman Mining Limited ( ($AU:TLM) ) has issued an update. Talisman Mining Limited has launched its first capital raising in over a decade, securi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/talisman-mining-raises-a4-million-to-fast-track-gold-exploration-and-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/talisman-mining-raises-a4-million-to-fast-track-gold-exploration-and-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864142","title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864142","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864142?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:09","pubTimestamp":1788304180,"startTime":"0","endTime":"0","summary":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson disposes of 9,000 shares for $422,874Craig C. Hopkinson, EVP R&D, Chief Medical Officer, sold 9,000 ordinary shares on Sep. 1 at USD 46.99.He","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLgbNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","FBT","PSIL","MEDX","IBRN","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855897","title":"Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855897?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"– Following productive FDA discussions, Upstream Bio will study 400 mg of verekitug administered every 12 weeks, versus placebo, in severe asthma and CRSwNP with one pivotal Phase 3 trial in each indi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353967/0/en/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-severe-asthma-and-crswnp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","TSLR","TEST","TSII","TSDD","TSLQ","09766","BBC","TSLW","07366","LABU","TESC","TSYY","TSLY","TLA","TESL","ELOL","07766","TSL","TSLZ","TSLG","TSLO","TSLS","09366","CRSH","TSLT","TSLI","TSLP","TSLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664858428","title":"Compass Pathways to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664858428","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664858428?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258620,"startTime":"0","endTime":"0","summary":"Compass Pathways to join Cantor Global Healthcare Conference fireside chatCompass Pathways will attend the 2026 Cantor Global Healthcare Conference on Sept. 9, 2026.Management is scheduled for a fireside chat at 3:20 p.m. ET.A panel session, “PSYCH! Accessing The New Wave of Psychedelics,” is set for 4:30 p.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Pathways plc published the original content used to generate this news brief via Business Wire  on September 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9r5Tyx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076208","title":"Dipietro Group Completes IPO Greenshoe, Raises €2.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076208?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167805,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Dipietro Group S.P.A ( ($IT:DPG) ). Dipietro Group S.p.A. has completed its IPO-related capital raising with th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dipietro-group-completes-ipo-greenshoe-raises-e2-1-million?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dipietro-group-completes-ipo-greenshoe-raises-e2-1-million?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPO","BK4127","BK4588","IPOS","FRHC","VGT","PSIL","BK4585","KCE","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663026000","title":"Alvo Minerals shareholders back prior capital raisings at general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663026000","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663026000?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:38","pubTimestamp":1788143921,"startTime":"0","endTime":"0","summary":"An update from Alvo Minerals Limited ( ($AU:ALV) ) is now available. Alvo Minerals has confirmed that shareholders at its 31 August general meeting...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alvo-minerals-shareholders-back-prior-capital-raisings-at-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alvo-minerals-shareholders-back-prior-capital-raisings-at-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTX","PSIL","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663009747","title":"AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2663009747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663009747?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:31","pubTimestamp":1787934678,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765646.SGD","IE0002141913.USD","IE00BBT3K403.USD","IYH","LU1989772840.SGD","IE000BZT7R73.USD","AGNG","SG9999011175.SGD","LU2089283258.USD","LU0726765562.USD","IE00B2B36J28.USD","LU0029864427.USD","MEDX","LU1670627923.USD","LU1267930490.SGD","IE00BSNM7G36.USD","LU1074936037.SGD","LU1496350171.SGD","IE0000B7K699.USD","FHLC","BBC","IE0004445239.USD","JDOC","LU1496350502.SGD","GLAM","PJP","LU1244550494.USD","PSIL","VHT","BK4585","ABBV","IE000SO60NU8.SGD","FTXH","LU2129689431.USD","PPH","LU0942090050.USD","BK4550","IXJ","LU2112291526.USD","LU0795875169.SGD","IE00B42XCP33.USD","IE00BLSP4239.USD","LU2237443465.HKD","TRUH","LU1934455194.USD","XLV","LU0057025933.USD","RXL","LU0985320562.USD","LU0868494708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663547097","title":"BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2663547097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663547097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:15","pubTimestamp":1787933700,"startTime":"0","endTime":"0","summary":"BioNTech ($BNTX) shares declined as much as 10% on Friday after the company said it has ended a key Phase 2 trial for its mRNA colorectal cancer va...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/biontech-stock-bntx-is-tumbling-on-friday-heres-why?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/biontech-stock-bntx-is-tumbling-on-friday-heres-why?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","PSIL","BK4588","BBC","BK4585","BK4548","BK4551","BK4139","BK4568","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662995717","title":"Unusually active option classes on open August 26th","url":"https://stock-news.laohu8.com/highlight/detail?id=2662995717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662995717?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:40","pubTimestamp":1787751623,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: COMPASS Pathways PLC (CMPS), Burlington Stores (BURL), Rackspace Technology (RXT), UP Fintech ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-august-26th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-august-26th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4008","LU2108987350.USD","LU0205194284.USD","UP","LU0205193047.USD","LU0077335932.USD","CMPS","BK4608","PSIL","BK4094","FTVI","BK4116","RXT","BURL","BK4566","LU1878469433.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662113637","title":"COMPASS Pathways (CMPS) Nears FDA Filing for COMP360 Following a Valuation Question","url":"https://stock-news.laohu8.com/highlight/detail?id=2662113637","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662113637?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:26","pubTimestamp":1787743564,"startTime":"0","endTime":"0","summary":"COMPASS Pathways (NasdaqGS:CMPS) is back in focus as investors watch the final stages of its planned FDA application for COMP360, a synthetic psilocybin treatment for people with treatment-resistant depression.\nOver the past year, COMPASS Pathways has seen strong momentum, with a year to date share price return of 127.18% and a 1 year total shareholder return of 212.61%. The recent 32.15% 30 day share price return suggests that enthusiasm around the FDA submission is building further.\nScan...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-nears-fda-filing-for-comp360-following","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-nears-fda-filing-for-comp360-following","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","PSIL","BK4588","BK4139","LABU","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795913","title":"Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795913","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795913?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:52","pubTimestamp":1787730745,"startTime":"0","endTime":"0","summary":"Sosei Group ( ($JP:4565) ) has provided an update. Nxera Pharma’s partner Neurocrine Biosciences has secured FDA IND acceptance for a Phase 2 trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nxera-to-book-us10m-milestone-as-fda-clears-phase-2-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nxera-to-book-us10m-milestone-as-fda-clears-phase-2-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","LABU","BK4585","PSIL","BK4588","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662067764","title":"FireFly announces successful A$190m capital raising to fund development and resource growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662067764","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662067764?lang=en_us&edition=fundamental","pubTime":"2026-08-26 11:53","pubTimestamp":1787716380,"startTime":"0","endTime":"0","summary":"Proceeds will be used for early works, long-lead items and resource drilling FireFly has received firm commitments to raise ~A$180m (before costs) via an Australian institutional placement and Canadia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351065/0/en/firefly-announces-successful-a-190m-capital-raising-to-fund-development-and-resource-growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PICK","LIFE","DBB","BK4173","BK4139","BMO","BK4207","BK4563","BK4535","XME","UYM","PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}